Investigation: To evaluate the value of the loop electrosurgical excision procedure (LEEP) for repeat low-grade squamous intraepithelial lesions (LSIL) with unsatisfactory colposcopy and the outcomes of postconization.
Methods: We performed LEEP in 136 patients and followed them up with colposcopy, cytology, and high-risk HPV (HR-HPV) detection using Hybrid Capture II (HCII).
Results: 55.1% of women had CIN 1 in the specimen, 17.6% had CIN 2-3, and 27.2% had no lesion. The sensitivity of detecting persistent/recurrent disease can reach 90.9% when positive post-treatment HR-HPV or first abnormal cervical cytology after LEEP are found, and the specificity is 95.3% when positive post-treatment HR-HPV coexisting with first abnormal cervical cytology after LEEP are detected.
Conclusion: Repeat LSIL with unsatisfactory colposcopy implies a significant risk of CIN 2-3. LEEP is a rational option to those patients with high-risk HPV infection or dysplastic endocervical curettage. Post-treatment follow-up of patients should include both cytology and HR-HPV testing.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Prognostic factors for low- and high grade squamous intraepithelial lesions in histological preparations following LLETZ procedure.
Wiad Lek
September 2024
DEPARTMENT OF GYNECOLOGIC ONCOLOGY, MEDICAL UNIVERSITY PLEVEN, PLEVEN, BULGARIA.
Article Synopsis
- - The study aims to explore various prognostic factors like age, hormonal status, histological results, and lesion characteristics that influence the outcomes of patients undergoing LLETZ treatment for cervical precancerous lesions.
- - Conducted between January 2017 and July 2021, the prospective study involved 189 patients and highlighted significant correlations between targeted biopsy results and colposcopic diagnoses concerning the final histological results after the LLETZ procedure.
- - Findings indicate that factors such as cervical lesion size and type are crucial in predicting the histological outcome, with larger lesions linked to higher risks of HSIL and cervical cancer.
2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023.
J Low Genit Tract Dis
January 2024
National Cancer Institute, Bethesda, MD.
This Research Letter summarizes all updates to the 2019 Guidelines through September 2023, including: endorsement of the 2021 Opportunistic Infections guidelines for HIV+ or immunosuppressed patients; clarification of use of human papillomavirus testing alone for patients undergoing observation for cervical intraepithelial neoplasia 2; revision of unsatisfactory cytology management; clarification that 2012 guidelines should be followed for patients aged 25 years and older screened with cytology only; management of patients for whom colposcopy was recommended but not completed; clarification that after treatment for cervical intraepithelial neoplasia 2+, 3 negative human papillomavirus tests or cotests at 6, 18, and 30 months are recommended before the patient can return to a 3-year testing interval; and clarification of postcolposcopy management of minimally abnormal results.
View Article and Find Full Text PDFDo women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?
Infect Agent Cancer
September 2023
Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, Suzhou, 215000, China.
Purpose: This study aimed to assess the value of an HPV E6/E7 mRNA assay and HPV 16 18/45 genotype assay combined with age stratification for triaging women negative for intraepithelial lesions or malignancy (NILM) cytology.
Methods: From January 2017 to December 2021, a total of 162,309 eligible women underwent cervical cancer screening at the Affiliated Hospital of Jining Medical University, China. Excluding those with negative HPV E6/E7 mRNA, abnormal and unsatisfactory cytology, and those who failed to undergo colposcopy, 6,845 women were ultimately included in our study.
The Value of Four-Quadrant Cervical Biopsy in Women with Different Colposcopic Impressions.
Diagnostics (Basel)
July 2023
Department of Obstetrics and Gynecology, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
The aim of this study was to compare the diagnostic efficacy of colposcopic-directed biopsy and four-quadrant biopsy in detecting high-grade cervical intra-epithelial neoplasia (CIN). Women attending three women's clinics for routine cervical screening were recruited. Colposcopy was arranged for women with any cytologic abnormalities greater than atypical squamous cells of undetermined significance (ASCUS), two consecutive ASCUS results or positive HPV testing.
View Article and Find Full Text PDFHistopathologic Follow-Up of Women with Inadequate ThinPrep™ Cervical Pap Tests and Positive High-Risk Human Papillomavirus Test Results.
Acta Cytol
October 2023
Department of Obstetrics and Gynecology, Istanbul Medeniyet University Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Istanbul, Turkey.
Introduction: We found only a few studies that had performed high-risk human papillomavirus (hrHPV) analyses of inadequate ThinPrep™ Papanicolaou (Pap) tests. Therefore, this study aimed to analyze unsatisfactory ThinPrep Pap tests using hrHPV tests. The colposcopic biopsy results of cases with an unsatisfactory ThinPrep Pap test and positive hrHPV results were revealed.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!